+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030

  • PDF Icon

    Report

  • 343 Pages
  • August 2023
  • Region: Global
  • iGATE Research
  • ID: 5390142
Description Jump to:

The global influenza vaccines market is projected to reach US$ 10.9 Billion by 2030. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza vaccination for all individuals 6 months of age and older. According to the World Health Organization (WHO), globally, about 3 to 5 million cases of severe influenza illness, and about 290,000 to 650,000 flu-related deaths are reported annually. The vast population base together with significantly low vaccination coverage in emerging markets, the introduction of new vaccines, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will drive the influenza vaccines market. The increasing R&D investments by leading market players, such as Sanofi, CSL Limited, and GlaxoSmithKline, for expanding manufacturing capabilities and focus on launching new vaccines will propel the market for influenza vaccines over the forecast period. However, shortage of vaccine supply due to the genetic assortment of the viral strains is surging the need for updating vaccines each year by the manufacturers. This is a major factor restraining market growth.

Recent Developments

  • In July 2023, Sinovac Biotech Ltd. announced an alliance with Indonesian state-owned biopharmaceutical company PT Bio Farma, to serve Indonesia's domestic vaccine market as well as international market.
  • In November 2022, Penn scientists developed a 20-subtype mRNA flu vaccine for protection against future flu pandemics.
  • In October 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination (CIC) vaccine candidate.
  • In March 2022, the Australian government invested more than US$ 100 million in the seasonal influenza vaccine to protect people at risk.

By Region: Influenza Vaccines Market and Forecast - Key Takeaways

  • Geographically, North America is the largest market for influenza vaccines capturing over 50% market share in 2022.
  • In the European region, almost all countries have national and/or regional vaccination policies or strategies for seasonal influenza in place.
  • Asia is expected to be the fastest growing market for influenza vaccines, driven by the increasing population in the Asian countries, growing focus of the governments on enhancing healthcare facilities, rising incidence of seasonal influenza, and rising disposable income.
  • Australasia accounted for least share of the influenza vaccines market in 2022.

By Country: Influenza Vaccines Market and Forecast - Key Takeaways

  • On country basis, United States captured highest share of the influenza vaccines market.
  • Japan is the second largest market for influenza vaccines.
  • China, Brazil, Canada, Australia, Germany, UK, and India are the other leading markets for influenza vaccines.
  • Poland is a country with one of the lowest influenza vaccination coverage rates among the EU member states.

By Company: Influenza Vaccines Market and Forecast - Key Takeaways

  • In 2022, GlaxoSmithKline plc influenza vaccines sales were up 5% over the prior year.
  • AstraZeneca influenza vaccines sales declined by 31% in 2022, owing to late start to the influenza season in Europe.
  • In September 2022, Pfizer Inc. initiated the phase 3 clinical study for mRNA-based influenza vaccine. The study enrolled 25,000 U.S. adults aged 18 years and older.
  • In 2021, Seqirus influenza vaccines sales increased by 37% over the prior year, driven by strong growth in seasonal influenza vaccines.
  • In October 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination (CIC) vaccine candidate.

The report titled “Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030” provides a comprehensive assessment of the fast-evolving, high-growth influenza vaccines market landscape.

This 343 Page report with 149 Figures and 7 Tables has been analyzed from 8 viewpoints:

1. Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2030)
2. By Region - Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2030)
3. Country Wise Distribution - Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2030)
4. Influenza Vaccines Market - Key Company Analysis
5. Influenza Vaccines Market - Emerging Players Profile
6. Global Influenza Vaccines Market - Major Deals
7. Global Influenza Vaccines Market - Recent Developments
8. Global Influenza Vaccines Market - Driving Factors and Challenges

By Region - Influenza Vaccines Market, Persons Vaccinated and Forecast

1. North America
2. Latin America
3. Europe
4. Asia
5. Australasia

Country Wise Distribution - Influenza Vaccines Market, Persons Vaccinated and Forecast

1. United States
2. Canada
3. Brazil
4. Mexico
5. Germany
6. France
7. Italy
8. Spain
9. United Kingdom
10. Netherlands
11. Ireland
12. Denmark
13. Luxembourg
14. Sweden
15. Finland
16. Belgium
17. Poland
18. Norway
19. Australia
20. New Zealand
21. Japan
22. China
23. India
24. South Korea
25. Singapore
26. Hong Kong
27. Malaysia
28. Thailand
29. Indonesia

Influenza Vaccines Market - Key Company Analysis

1. GlaxoSmithKline (GSK)
2. Sanofi
3. Seqirus (CSL Limited)
4. Abbott
5. AstraZeneca
6. Gamma Vaccines Pty Ltd.
7. Hualan Bioengineering Co., Ltd
8. Mylan (Now Part of Viatris)
9. BioDiem
10. Shanghai Institute of Biological Products Co., Ltd.

Influenza Vaccines Market - Emerging Players Profile

1. Novavax
2. Medicago
3. Moderna Inc.
4. Pneumagen
5. Daiichi-Sankyo
6. FluGen
7. Imutex
8. EpiVax
9. Versatope Therapeutics, Inc.
10. BiondVax Pharmaceuticals Ltd.
11. BIKEN Co., Ltd.
12. Sinovac Biotech
13. Emergent BioSolutions
14. Osivax
15. Emergex Vaccines

Data Sources

The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and in-house analysis by the publisher's dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

 

Table of Contents


1. Executive Summary
2. Global - Influenza Vaccines Market and Forecast (2011 - 2030)
2.1 Global - Influenza Vaccines Market and Forecast
2.2 Global - Number of Persons Vaccinated with Influenza Vaccines and Forecast

3. Global - Influenza Vaccines Market Share and Forecast (2011 - 2030)
3.1 Influenza Vaccines Market Share and Forecast - Regional Analysis
3.2 Persons Vaccinated with Influenza Vaccines Share and Forecast - Regional Analysis

4. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2030)
4.1 North America - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.1.1 North America - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.1.2 North America - Influenza Vaccines Market and Forecast
4.2 Latin America - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.2.1 Latin America - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.2.2 Latin America - Influenza Vaccines Market and Forecast
4.3 Europe - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.3.1 Europe - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.3.2 Europe - Influenza Vaccines Market and Forecast
4.4 Asia - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.4.1 Asia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.4.2 Asia - Influenza Vaccines Market and Forecast
4.5 Australasia - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.5.1 Australasia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.5.2 Australasia - Influenza Vaccines Market and Forecast

5. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2030)
5.1 United States - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.1.1 United States - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.1.2 United States - Influenza Vaccines Market and Forecast
5.2 Canada - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.2.1 Canada - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.2.2 Canada - Influenza Vaccines Market and Forecast
5.3 Brazil - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.3.1 Brazil - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.3.2 Brazil - Influenza Vaccines Market and Forecast
5.4 Mexico - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.4.1 Mexico - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.4.2 Mexico - Influenza Vaccines Market and Forecast
5.5 Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.5.1 Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.5.2 Germany - Influenza Vaccines Market and Forecast
5.6 France - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.6.1 France - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.6.2 France - Influenza Vaccines Market and Forecast
5.7 Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.7.1 Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.7.2 Italy - Influenza Vaccines Market and Forecast
5.8 Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.8.1 Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.8.2 Spain - Influenza Vaccines Market and Forecast
5.9 United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.9.1 United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.9.2 United Kingdom - Influenza Vaccines Market and Forecast
5.10 Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.10.1 Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.10.2 Netherlands - Influenza Vaccines Market and Forecast
5.11 Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.11.1 Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.11.2 Ireland - Influenza Vaccines Market and Forecast
5.12 Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.12.1 Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.12.2 Denmark - Influenza Vaccines Market and Forecast
5.13 Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.13.1 Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.13.2 Luxembourg - Influenza Vaccines Market and Forecast
5.14 Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.14.1 Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.14.2 Sweden - Influenza Vaccines Market and Forecast
5.15 Finland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.15.1 Finland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.15.2 Finland - Influenza Vaccines Market and Forecast
5.16 Belgium - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.16.1 Belgium - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.16.2 Belgium - Influenza Vaccines Market and Forecast
5.17 Poland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.17.1 Poland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.17.2 Poland - Influenza Vaccines Market and Forecast
5.18 Norway - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.18.1 Norway - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.18.2 Norway - Influenza Vaccines Market and Forecast
5.19 Australia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.19.1 Australia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.19.2 Australia - Influenza Vaccines Market and Forecast
5.20 New Zealand - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.20.1 New Zealand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.20.2 New Zealand - Influenza Vaccines Market and Forecast
5.21 Japan - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.21.1 Japan - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.21.2 Japan - Influenza Vaccines Market and Forecast
5.22 China - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.22.1 China - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.22.2 China - Influenza Vaccines Market and Forecast
5.23 India - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.23.1 India - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.23.2 India - Influenza Vaccines Market and Forecast
5.24 South Korea - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.24.1 South Korea - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.24.2 South Korea - Influenza Vaccines Market and Forecast
5.25 Thailand - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.25.1 Thailand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.25.2 Thailand - Influenza Vaccines Market and Forecast
5.26 Singapore - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.26.1 Singapore - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.26.2 Singapore - Influenza Vaccines Market and Forecast
5.27 Hong Kong - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.27.1 Hong Kong - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.27.2 Hong Kong - Influenza Vaccines Market and Forecast
5.28 Malaysia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.28.1 Malaysia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.28.2 Malaysia - Influenza Vaccines Market and Forecast
5.29 Indonesia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.29.1 Indonesia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.29.2 Indonesia - Influenza Vaccines Market and Forecast

6. Global Influenza Vaccines Market - Key Company Analysis
6.1 GlaxoSmithKline (GSK)
6.1.1 Business Overview
6.1.2 Influenza Vaccines Portfolio
6.1.3 Global - GSK Influenza Vaccines Sales and Forecast (2007 - 2030)
6.1.4 Promising Influenza Vaccines in the Clinical Development
6.1.5 Recent Developments
6.2 Sanofi Pasteur
6.2.1 Business Overview
6.2.2 Influenza Vaccines Portfolio
6.2.3 Global - Sanofi Influenza Vaccines Sales and Forecast (2009 - 2030)
6.2.4 Promising Influenza Vaccines in the Clinical Development
6.2.5 Recent Developments
6.3 Seqirus (CSL Limited)
6.3.1 Business Overview
6.3.2 Influenza Vaccines Portfolio
6.3.3 Global - Seqirus Influenza Vaccines Sales and Forecast (2016 - 2030)
6.3.4 Promising Influenza Vaccines in the Clinical Development
6.3.5 Recent Developments
6.4 Global - Influvac (Acquired by Abbott) Sales (2007 - 2009)
6.5 AstraZeneca
6.5.1 Business Overview
6.5.2 Influenza Vaccines Portfolio
6.5.3 Global - AstraZeneca Influenza Vaccines Sales and Forecast (2007 - 2030)
6.6 Gamma Vaccines Pty Ltd.
6.6.1 Business Overview
6.6.2 Influenza Vaccines Portfolio
6.6.3 Recent Developments
6.7 Hualan Bioengineering Co., Ltd.
6.7.1 Business Overview
6.7.2 Influenza Vaccines Portfolio
6.7.3 Recent Developments
6.8 Mylan (Now Part of Viatris)
6.8.1 Business Overview
6.8.2 Influenza Vaccines Portfolio
6.9 BioDiem
6.9.1 Business Overview
6.9.2 Influenza Vaccines Portfolio
6.9.3 Recent Developments
6.10 Shanghai Institute of Biological Products Co., Ltd.
6.10.1 Business Overview
6.10.2 Influenza Vaccines Portfolio

7. Global Influenza Vaccines Market - Emerging Players Profile
7.1 Novavax
7.1.1 Business Overview
7.1.2 Promising Influenza Vaccines in Clinical Development
7.1.3 Recent Developments
7.2 Medicago
7.2.1 Business Overview
7.2.2 Promising Influenza Vaccines in Clinical Development
7.2.3 Recent Developments
7.3 Moderna Inc.
7.3.1 Business Overview
7.3.2 Promising Influenza Vaccines in Clinical Development
7.3.3 Recent Developments
7.4 Pneumagen
7.4.1 Business Overview
7.4.2 Promising Influenza Vaccines in Clinical Development
7.4.3 Recent Developments
7.5 Daiichi-Sankyo
7.5.1 Business Overview
7.5.1 Influenza Vaccines Portfolio
7.5.2 Recent Developments
7.6 FluGen
7.6.1 Business Overview
7.6.2 Promising Influenza Vaccines in Clinical Development
7.6.3 Recent Developments
7.7 Imutex
7.7.1 Business Overview
7.7.2 Promising Influenza Vaccines in Clinical Development
7.7.3 Recent Developments
7.8 EpiVax
7.8.1 Business Overview
7.8.2 Promising Influenza Vaccines in Clinical Development
7.8.3 Recent Developments
7.9 Versatope Therapeutics, Inc.
7.9.1 Business Overview
7.9.2 Promising Influenza Vaccines in Clinical Development
7.9.3 Recent Developments
7.10 BiondVax Pharmaceuticals Ltd.
7.10.1 Business Overview
7.10.2 Promising Influenza Vaccines in Clinical Development
7.11 BIKEN Co., Ltd.
7.11.1 Business Overview
7.11.2 Influenza Vaccines Portfolio
7.12 Sinovac Biotech
7.12.1 Business Overview
7.12.2 Influenza Vaccines Portfolio
7.12.3 Recent Developments
7.13 Emergent BioSolutions
7.13.1 Business Overview
7.13.1 Promising Influenza Vaccines in Clinical Development
7.13.2 Recent Developments
7.14 Osivax
7.14.1 Business Overview
7.14.2 Promising Influenza Vaccines in Clinical Development
7.14.1 Recent Developments
7.15 Emergex Vaccines
7.15.1 Business Overview
7.15.2 Promising Influenza Vaccines in Clinical Development
7.15.3 Recent Developments

8. Global Influenza Vaccines Market - Major Deals
8.1 Mergers and Acquisitions
8.2 Licensing Agreements
8.3 Collaboration Agreements

9. Global Influenza Vaccines Market - Recent Developments
10. Global Influenza Vaccines Market - Driving Factors
10.1 Transformation of Vaccine Technologies
10.2 Vaccines most Cost-Effective Means of Disease Prevention
10.3 Scientific & Technological Breakthroughs
10.4 Growing Awareness and Adoption of Influenza Vaccines Due to Increasing Government Support for Immunization
10.5 Robust R&D Investments with Strong Pipeline Candidates to Drive Market Growth

11. Global Influenza Vaccines Market - Challenges
11.1 Complexity of Vaccine Development and Approval System Thwarts Product Development
11.1.1 Legal Obstacles
11.1.2 General Technical Barriers
11.1.3 Economic Barriers
11.1.4 Regulatory Barriers
11.2 Hurdles to Optimal use of Licensed Vaccines
11.2.1 Technical Obstacles
11.2.2 Economic Obstacles
11.2.3 Cultural Obstacles
11.3 Barriers to New Entrants in the Vaccines Market
11.4 Reducing the Timeline for Vaccine Development
11.5 Challenges Faced by Healthcare Workers in Immunization

List of Figures:
Figure 2-1: Global - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 2-2: Global - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 2-3: Global - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 2-4: Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 4-1: North America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 4-2: North America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 4-3: North America - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 4-4: North America - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 4-5: Latin America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 4-6: Latin America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 4-7: Latin America - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 4-8: Latin America - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 4-9: Europe - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 4-10: Europe - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 4-11: Europe - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 4-12: Europe - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 4-13: Asia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 4-14: Asia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 4-15: Asia - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 4-16: Asia - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 4-17: Australasia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 4-18: Australasia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 4-19: Australasia - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 4-20: Australasia - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-11: Brazil - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-15: Mexico - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-17: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-18: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-19: Germany - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-20: Germany - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-21: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-22: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-23: France - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-24: France - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-25: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-26: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-27: Italy - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-28: Italy - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-29: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-30: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-31: Spain - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-32: Spain - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-33: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-34: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-35: United Kingdom - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-36: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-37: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-38: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-39: Netherlands - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-40: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-41: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-42: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-43: Ireland - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-44: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-45: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-46: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-47: Denmark - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-48: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-49: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-50: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-51: Luxembourg - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-52: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-53: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-54: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-55: Sweden - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-56: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-57: Finland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-58: Finland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-59: Finland - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-60: Finland - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-61: Belgium - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-62: Belgium - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-63: Belgium - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-64: Belgium - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-65: Poland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-66: Poland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-67: Poland - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-68: Poland - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-69: Norway - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-70: Norway - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-71: Norway - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-72: Norway - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-73: Australia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-74: Australia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-75: Australia - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-76: Australia - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-77: New Zealand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-78: New Zealand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-79: New Zealand - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-80: New Zealand - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-81: Japan - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-82: Japan - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-83: Japan - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-84: Japan - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-85: China - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-86: China - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-87: China - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-88: China - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-89: India - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-90: India - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-91: India - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-92: India - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-93: South Korea - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-94: South Korea - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-95: South Korea - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-96: South Korea - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-97: Thailand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-98: Thailand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-99: Thailand - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-100: Thailand - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-101: Singapore - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-102: Singapore - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-103: Singapore - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-104: Singapore - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-105: Hong Kong - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-106: Hong Kong - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-107: Hong Kong - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-108: Hong Kong - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-109: Malaysia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-110: Malaysia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-111: Malaysia - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-112: Malaysia - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 5-113: Indonesia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2022
Figure 5-114: Indonesia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2023 - 2030
Figure 5-115: Indonesia - Influenza Vaccines Market (Million US$), 2011 - 2022
Figure 5-116: Indonesia - Forecast for Influenza Vaccines Market (Million US$), 2023 - 2030
Figure 6-1: Global - GlaxoSmithKline plc Influenza Vaccines Sales (Million US$), 2007 - 2022
Figure 6-2: Global - Forecast for GlaxoSmithKline plc Influenza Vaccines Sales (Million US$), 2023 - 2030
Figure 6-3: Global - Sanofi Influenza Vaccines Sales (Million US$), 2009 - 2022
Figure 6-4: Global - Forecast for Sanofi Influenza Vaccines Sales (Million US$), 2023 - 2030
Figure 6-5: Global - Seqirus Influenza Vaccines Sales (Million US$), 2016 - 2022
Figure 6-6: Global - Forecast for Seqirus Influenza Vaccines Sales (Million US$), 2023 - 2030
Figure 6-7: Global - Influvac Influenza Vaccines Sales (Million US$), 2007 - 2009
Figure 6-8: Global - AstraZeneca Influenza Vaccines Sales (Million US$), 2007 - 2022
Figure 6-9: Global - Forecast for AstraZeneca Influenza Vaccines Sales (Million US$), 2023 - 2030

List of Tables:
Table 3-1: Region Wise - Influenza Vaccines Market Share (Percent), 2011 - 2022
Table 3-2: Region Wise - Forecast for Influenza Vaccines Market Share (Percent), 2023 - 2030
Table 3-3: Region Wise - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2022
Table 3-4: Region Wise - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2023 - 2030
Table 8-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2022
Table 8-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2022
Table 8-3: Global - Collaboration Agreement in Influenza Vaccines Market (Million US$), 2019 - 2023

Companies Mentioned

  • GlaxoSmithKline (GSK)
  • Sanofi 
  • Seqirus (CSL Limited)
  • Abbott
  • AstraZeneca
  • Gamma Vaccines Pty Ltd.
  • Hualan Bioengineering Co., Ltd
  • Mylan (Now Part of Viatris)
  • BioDiem
  • Shanghai Institute of Biological Products Co., Ltd.
  • Novavax
  • Medicago
  • Moderna Inc.
  • Pneumagen
  • Daiichi–Sankyo
  • FluGen 
  • Imutex
  • EpiVax
  • Versatope Therapeutics, Inc.
  • BiondVax Pharmaceuticals Ltd.
  • BIKEN Co., Ltd.
  • Sinovac Biotech
  • Emergent BioSolutions
  • Osivax
  • Emergex Vaccines

Related Topics

Related Reports

Vaccines Global Market Opportunities And Strategies To 2031 - Product Image

Vaccines Global Market Opportunities And Strategies To 2031

  • Report
  • 343 Pages
  • Global
From
Drug Discovery Global Market Report 2023 - Product Image

Drug Discovery Global Market Report 2023

  • Report
  • 200 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • 250 Pages
  • Global
From
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032 - Product Image

Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032

  • Report
  • 38 Pages
  • Global
From
Global Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Forecast 2023-2030 - Product Image

Global Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Forecast 2023-2030

  • Report
  • 186 Pages
  • Global
From

About the Market

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions. Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques. Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2023 Research and Markets. All Rights Reserved.